Application
K0746 Antibody (N-term) western blot analysis in U251 cell line lysates (35ug/lane).This demonstrates the K0746 antibody detected the K0746 protein (arrow).Application
K0746 Antibody (N-term) flow cytometric analysis of U251 cells (right histogram) compared to a negative control cell (left histogram).FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis.| Product Name | K0746 Antibody (N-term) |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | SEL1L3; KIAA0746; Protein sel-1 homolog 3; Suppressor of lin-12-like protein 3 |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WBFC |
| WB:1:100~500 FC |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Gene Synonyms | KIAA0746 |
|---|---|
| Alternative Names | SEL1L3 KIAA0746 Protein sel-1 homolog 3 Suppressor of lin-12-like protein 3 |
| Molecular Weight(MW) | 128567 Da |
| Tissue Specificity | This K0746 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 260-290 amino acids from the N-terminal region of human K0746. |
| Cellular Localization | Membrane; Single-pass membrane protein (Potential) |
| Entrez Gene | 23231 |
|---|---|
| Nucleotide Accession | NP_056002.2 |
Application
K0746 Antibody (N-term) western blot analysis in U251 cell line lysates (35ug/lane).This demonstrates the K0746 antibody detected the K0746 protein (arrow).
Application
K0746 Antibody (N-term) flow cytometric analysis of U251 cells (right histogram) compared to a negative control cell (left histogram).FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis.| Application Notes | WB:1:100~500 FC |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
